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Abstract
It is estimated that half of all trials have never been published which can lead to
patients being denied the most effective treatment and being exposed to
unnecessary side effects.  Furthermore the trial participants have been
misinformed since the trial results have not contributed to the care of future
patients.
 
However the non-publication of trials is often not due to a deliberate decision to
cover up results.  Commonly in academia it is due to more understandable
reasons such as researchers having busy clinical posts, moving onto other
more demanding projects, changing research areas or starting a family.  This is
called the “file drawer” problem.
 
The examples in this editorial demonstrate that it is possible to go back, even
decades later, and make the results available to inform future evidence based
medicine.  We call on others to look into their “file drawer” for unpublished trials.
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The process by which a medical intervention is thought to be effec-
tive is now well described. Data from trials are collected together 
after a systematic search of the literature. These are then pooled in a 
meta-analysis to give an overall indication of efficacy. These results 
are then collated to inform policy documents, such as guidelines 
produced by the National Institute for Health and Care Excellence 
(NICE) in England and Wales. However any meta-analysis is only 
as good as the trials which it includes. Missing data such as that 
which comes from unpublished trials is a serious threat to the integ-
rity of any systematic review.
It is estimated that half of all trials have never been published and 
the incidence of non-publication is roughly similar whether a trial 
is funded by industry, governments or academia1. Therefore unpub-
lished trials can lead to patients being denied the most effective 
treatment, or being exposed to ineffective treatments, or to unnec-
essary side effects. Furthermore the trial participants, who invested 
their time and placed themselves at potential risk of side effects, 
being on placebo or an ineffective treatment, have been misin-
formed since the trial results have not contributed to the care of 
future patients.
However the non-publication of trials is often not due to a deliber-
ate decision to cover up results. Commonly in academia it is due to 
more understandable reasons such as researchers having busy clini-
cal posts, moving onto other more demanding projects, changing 
research areas or starting a family. This is called the “file drawer” 
problem.
Many steps are currently being taken to address the non-publica-
tion of trials, such as enforcing trial registration. However imple-
menting this type of action prospectively will not affect the current 
evidence base for some time. Therefore reducing publication bias 
partly depends on researchers pursuing the publication of trials that 
are sitting in the “file drawer”.
Doshi et al. have made a call for action2. They have asked investiga-
tors of unpublished trials to either publish their trial within one year 
or allow their trial data to be made public so that it can be prepared 
for publication by others. This concept is called ‘Restoring Invis-
ible and Abandoned Trials’ (RIAT). Furthermore the paper sets out 
a minimum set of criteria for responsible publication of abandoned 
trials.
The first paper to be published under the RIAT initiative was a trial 
that was conducted 20 years ago and involved 1447 bowel cancer 
patients3. Treasure et al. contacted the trial investigators to ask for 
their permission to re-analyse the results and publish the trial. The 
trial investigators supported this work and now finally the efforts of 
the trial participants have contributed to the evidence base.
A further example of a recovered trial is a clinical trial on poly-
cythaemia that was not published due to several setbacks includ-
ing researchers retiring, data being lost during a relocation of its 
administrative centre, and journals refusing to publish a partially 
completed trial. Despite all these issues, the results of the trial 
have now been reported as an attachment to a commentary in 
the journal Trials which is specifically interested in unpublished 
trials4.
A final example is a randomised controlled trial of Brief Alcohol 
Interventions5. This trial was not published for 17 years due to 
researchers moving abroad and taking on other demanding jobs. 
Therefore, I was asked by the researchers to prepare the trial for 
publication by updating the introduction and discussion. As a 
medical student with plenty of time, I was very keen to assist. Now 
finally the results are available to contribute to future meta-analyses.
These examples demonstrate that it is possible to go back, even 
decades later, and make the results available to inform future evi-
dence based medicine. We call on others to look into their “file 
drawer” for unpublished trials. There is plenty of assistance avail-
able to make publication as easy as possible, for example by asking 
others to update the manuscript or publishing through dedicated 
journals such as Trials or F1000 Research. It is never too late to 
publish an abandoned trial.
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